Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Brand

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Journal of Hypertension|December 23, 2004
Association of peripheral and central arterial wave reflections with the CYP11B2 -344C allele and sodium excretionWiktoria Wojciechowska, Jan A Staessen, Katarzyna Stolarz, et al.
Orphanet Journal of Rare Diseases|July 1, 2016
Multicenter Female Fabry Study (MFFS) - clinical survey on current treatment of females with Fabry diseaseMalte Lenders, Julia B Hennermann, Christine Kurschat, et al.
ESC Heart Failure|February 27, 2020
Cardiomyopathy and kidney function in agalsidase beta-treated female Fabry patients: a pre-treatment vs. post-treatment analysisChristoph Wanner, Ulla Feldt-Rasmussen, Ana Jovanovic, et al.
Journal of Inherited Metabolic Disease|July 20, 2024
Renal and multisystem effectiveness of 3.9 years of migalastat in a global real-world cohort: Results from the followME Fabry Pathfinders registryDerralynn A Hughes, Gere Sunder-Plassmann, Ana Jovanovic, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 6, 2009
Left ventricular structure in relation to the human SAH gene in the European Project on Genes in HypertensionYu Jin, Tatiana Kuznetsova, Valérie Tikhonoff, et al.
Journal of Hypertension|March 2, 2006
Sodium excretion as a modulator of genetic associations with cardiovascular phenotypes in the European Project on Genes in HypertensionTatiana Kuznetsova, Jan A Staessen, Eva Brand, et al.
Atherosclerosis|March 14, 2009
Osteopontin gene variation and cardio/cerebrovascular disease phenotypesKlaus Schmidt-Petersen, Eva Brand, Ralph Telgmann, et al.
Journal of Hypertension|February 7, 2007
SAH gene variants are associated with obesity-related hypertension in Caucasians: the PEGASE StudyRalph Telgmann, Eva Brand, Viviane Nicaud, et al.
Pharmacogenomics|October 7, 2005
OASIS-HT: design of a pharmacogenomic dose-finding studyJan A Staessen, Tatiana Kuznetsova, Rok Acceto, et al.
Molecular Genetics and Metabolism|January 29, 2023
Clinical outcomes among young patients with Fabry disease who initiated agalsidase beta treatment before 30 years of age: An analysis from the Fabry RegistryRobert J Hopkin, Gustavo H Cabrera, John L Jefferies, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Journal of Hypertension|December 23, 2004
Association of peripheral and central arterial wave reflections with the CYP11B2 -344C allele and sodium excretionWiktoria Wojciechowska, Jan A Staessen, Katarzyna Stolarz, et al.
Orphanet Journal of Rare Diseases|July 1, 2016
Multicenter Female Fabry Study (MFFS) - clinical survey on current treatment of females with Fabry diseaseMalte Lenders, Julia B Hennermann, Christine Kurschat, et al.
ESC Heart Failure|February 27, 2020
Cardiomyopathy and kidney function in agalsidase beta-treated female Fabry patients: a pre-treatment vs. post-treatment analysisChristoph Wanner, Ulla Feldt-Rasmussen, Ana Jovanovic, et al.
Journal of Inherited Metabolic Disease|July 20, 2024
Renal and multisystem effectiveness of 3.9 years of migalastat in a global real-world cohort: Results from the followME Fabry Pathfinders registryDerralynn A Hughes, Gere Sunder-Plassmann, Ana Jovanovic, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 6, 2009
Left ventricular structure in relation to the human SAH gene in the European Project on Genes in HypertensionYu Jin, Tatiana Kuznetsova, Valérie Tikhonoff, et al.
Journal of Hypertension|March 2, 2006
Sodium excretion as a modulator of genetic associations with cardiovascular phenotypes in the European Project on Genes in HypertensionTatiana Kuznetsova, Jan A Staessen, Eva Brand, et al.
Atherosclerosis|March 14, 2009
Osteopontin gene variation and cardio/cerebrovascular disease phenotypesKlaus Schmidt-Petersen, Eva Brand, Ralph Telgmann, et al.
Journal of Hypertension|February 7, 2007
SAH gene variants are associated with obesity-related hypertension in Caucasians: the PEGASE StudyRalph Telgmann, Eva Brand, Viviane Nicaud, et al.
Pharmacogenomics|October 7, 2005
OASIS-HT: design of a pharmacogenomic dose-finding studyJan A Staessen, Tatiana Kuznetsova, Rok Acceto, et al.
Molecular Genetics and Metabolism|January 29, 2023
Clinical outcomes among young patients with Fabry disease who initiated agalsidase beta treatment before 30 years of age: An analysis from the Fabry RegistryRobert J Hopkin, Gustavo H Cabrera, John L Jefferies, et al.
Pageof 13